-
1
-
-
16844365788
-
+ regulatory T cells in immunological tolerance to self and non-self
-
+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345-352
-
(2005)
Nat Immunol
, vol.6
, pp. 345-352
-
-
Sakaguchi, S.1
-
2
-
-
0035180065
-
+ regulatory T cells: Their common role in controlling autoimmunity, tumour immunity and transplantation tolerance
-
+ regulatory T cells: their common role in controlling autoimmunity, tumour immunity and transplantation tolerance. Immunol Rev 182:18-32
-
(2001)
Immunol Rev
, vol.182
, pp. 18-32
-
-
Sakaguchi, S.1
Sakaguchi, N.2
Shimizu, J.3
Yamazaki, S.4
Sakihama, T.5
Itoh, M.6
Kuniyasu, Y.7
Nomura, T.8
Toda, M.9
Takahashi, T.10
-
3
-
-
33645286546
-
Regulatory T cells, tumour immunity and immunotherapy
-
Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295-307
-
(2006)
Nat Rev Immunol
, vol.6
, pp. 295-307
-
-
Zou, W.1
-
4
-
-
12244294476
-
Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer
-
Solomayer EF, Feuerer M, Bai L, Umansky V, Beckhove P, Meyberg GC, Bastert G, Schirrmacher V, Diel IJ (2003) Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. Clin Cancer Res 9:174-180 (Pubitemid 36109730)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.1 I
, pp. 174-180
-
-
Solomayer, E.-F.1
Feuerer, M.2
Bai, L.3
Umansky, V.4
Beckhove, P.5
Meyberg, G.C.6
Bastert, G.7
Schirrmacher, V.8
Diel, I.J.9
-
5
-
-
21244484329
-
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells
-
DOI 10.1111/j.1365-2567.2005.02163.x
-
Mahnke YD, Schwendemann J, Beckhove P, Schirrmacher V (2005) Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells. Immunology 115:325-336 (Pubitemid 40896031)
-
(2005)
Immunology
, vol.115
, Issue.3
, pp. 325-336
-
-
Mahnke, Y.D.1
Schwendemann, J.2
Beckhove, P.3
Schirrmacher, V.4
-
6
-
-
10744221289
-
+ Regulatory T Cells
-
DOI 10.1084/jem.20031562
-
Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, Debes GF, Lauber J, Frey O, Przybylski GK, Niesner U, de la Rosa M, Schmidt CA, Bräuer R, Buer J, Scheffold A, Hamann A (2004) Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 199:303-313 (Pubitemid 38252043)
-
(2004)
Journal of Experimental Medicine
, vol.199
, Issue.3
, pp. 303-313
-
-
Huehn, J.1
Siegmund, K.2
Lehmann, J.C.U.3
Siewert, C.4
Haubold, U.5
Feuerer, M.6
Debes, G.F.7
Lauber, J.8
Frey, O.9
Przybylski, G.K.10
Niesner, U.11
De La, R.M.12
Schmidt, C.A.13
Brauer, R.14
Buer, J.15
Scheffold, A.16
Hamann, A.17
-
7
-
-
77952391928
-
Tumor regulatory T cells potently abrogate antitumour immunity
-
Liu Z, Kim JH, Falo LD Jr, You Z (2009) Tumor regulatory T cells potently abrogate antitumour immunity. J Immunol 182:6160-6167
-
(2009)
J Immunol
, vol.182
, pp. 6160-6167
-
-
Liu, Z.1
Kim, J.H.2
Falo Jr., L.D.3
You, Z.4
-
8
-
-
70449360735
-
Antigen-specific Tregs control T-cell responses against a limited repertoire of tumour antigens in patients with colorectal carcinoma
-
Bonertz A, Weitz J, Pietsch DH, Rahbari NN, Schlude C, Ge Y, Juenger S, Vlodavsky I, Khazaie K, Jaeger D, Reissfelder C, Antolovic D, Aigner M, Koch M, Beckhove P (2009) Antigen-specific Tregs control T-cell responses against a limited repertoire of tumour antigens in patients with colorectal carcinoma. J Clin Invest 119:3311-3321
-
(2009)
J Clin Invest
, vol.119
, pp. 3311-3321
-
-
Bonertz, A.1
Weitz, J.2
Pietsch, D.H.3
Rahbari, N.N.4
Schlude, C.5
Ge, Y.6
Juenger, S.7
Vlodavsky, I.8
Khazaie, K.9
Jaeger, D.10
Reissfelder, C.11
Antolovic, D.12
Aigner, M.13
Koch, M.14
Beckhove, P.15
-
9
-
-
0036721629
-
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
-
Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumour microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756-2761 (Pubitemid 34921025)
-
(2002)
Journal of Immunology
, vol.169
, Issue.5
, pp. 2756-2761
-
-
Liyanage, U.K.1
Moore, T.T.2
Joo, H.-G.3
Tanaka, Y.4
Herrmann, V.5
Doherty, G.6
Drebin, J.A.7
Strasberg, S.M.8
Eberlein, T.J.9
Goedegebuure, P.S.10
Linehan, D.C.11
-
10
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
DOI 10.1038/nm1093
-
Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Erdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zim Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942-949 (Pubitemid 39273735)
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
Zhu, Y.11
Wei, S.12
Kryczek, I.13
Daniel, B.14
Gordon, A.15
Myers, L.16
Lackner, A.17
Disis, M.L.18
Knutson, K.L.19
Chen, L.20
Zou, W.21
more..
-
11
-
-
0035874949
-
+) T cells in tumours from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
-
+) T cells in tumours from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61:4766-4772
-
(2001)
Cancer Res
, vol.61
, pp. 4766-4772
-
-
Woo, E.Y.1
Chu, C.S.2
Goletz, T.J.3
Schlienger, K.4
Yeh, H.5
Coukos, G.6
Rubin, S.C.7
Kaiser, L.R.8
June, C.H.9
-
12
-
-
3142737258
-
+ CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells
-
+ CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173:1444-1453
-
(2004)
J Immunol
, vol.173
, pp. 1444-1453
-
-
Viguier, M.1
Lemaître, F.2
Verola, O.3
Cho, M.S.4
Gorochov, G.5
Dubertret, L.6
Bachelez, H.7
Konrilsky, P.8
Ferradini, L.9
-
13
-
-
1642378018
-
+ regulatory T cells suppress tumour immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumours to be curative
-
+ regulatory T cells suppress tumour immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumours to be curative. Eur J Immunol 34:336-344
-
(2004)
Eur J Immunol
, vol.34
, pp. 336-344
-
-
Ghiringhelli, F.1
Larmonier, N.2
Schmitt, E.3
Parcellier, A.4
Cathelin, D.5
Garrido, C.6
Chauffert, B.7
Solary, E.8
Bonnotte, B.9
Martin, F.10
-
15
-
-
33847368549
-
+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
-
+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 56:641-648
-
(2007)
Cancer Immunol Immunother
, vol.56
, pp. 641-648
-
-
Ghiringhelli, F.1
Menard, C.2
Puig, P.E.3
Ladoire, S.4
Roux, S.5
Martin, F.6
Solary, E.7
Le Cesne, A.8
Zitvogel, L.9
Chauffert, B.10
-
16
-
-
0035048973
-
Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow
-
DOI 10.1038/86523
-
Feuerer M, Beckhove P, Bai L, Solomayer EF, Bastert G, Diel IJ, Pedain C, Oberniedermayr M, Schirrmacher V, Umansky V (2001) Therapy of human tumours in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat Med 7:452-458 (Pubitemid 32298548)
-
(2001)
Nature Medicine
, vol.7
, Issue.4
, pp. 452-458
-
-
Feuerer, M.1
Beckhove, P.2
Bai, L.3
Solomayer, E.-F.4
Bastert, G.5
Diel, I.J.6
Pedain, C.7
Oberniedermayr, M.8
Schirrmacher, V.9
Umansky, V.10
-
17
-
-
34547725204
-
+ regulatory T cell infiltration of human pancreatic carcinoma
-
+ regulatory T cell infiltration of human pancreatic carcinoma. J Natl Cancer Inst 99:1188-1199
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 1188-1199
-
-
Nummer, D.1
Suri-Payer, E.2
Schmitz-Winnenthal, H.3
Bonertz, A.4
Galindo, L.5
Antolovich, D.6
Koch, M.7
Büchler, M.8
Weitz, J.9
Schirrmacher, V.10
Beckhove, P.11
-
18
-
-
0015762456
-
A human cell line from a pleural effusion derived from a breast carcinoma
-
Soule HD, Vazguez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1416
-
(1973)
J Natl Cancer Inst
, vol.51
, pp. 1409-1416
-
-
Soule, H.D.1
Vazguez, J.2
Long, A.3
Albert, S.4
Brennan, M.5
-
19
-
-
0037524280
-
Expression of tumour markers on breast and ovarian cancer cell lines
-
Kämmerer U, Thanner F, Kapp M, Dietl J, Sütterlin M (2003) Expression of tumour markers on breast and ovarian cancer cell lines. Anticancer Res 23:1051-1055
-
(2003)
Anticancer Res
, vol.23
, pp. 1051-1055
-
-
Kämmerer, U.1
Thanner, F.2
Kapp, M.3
Dietl, J.4
Sütterlin, M.5
-
20
-
-
11944262611
-
A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo
-
DOI 10.1007/s00262-004-0583-z
-
Gückel B, Stumm S, Rentzsch C, Marmé A, Mannhardt G, Wallwiener D (2005) A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo. Cancer Immunol Immunother 54:129-140 (Pubitemid 40100835)
-
(2005)
Cancer Immunology, Immunotherapy
, vol.54
, Issue.2
, pp. 129-140
-
-
Guckel, B.1
Stumm, S.2
Rentzsch, C.3
Marme, A.4
Mannhardt, G.5
Wallwiener, D.6
-
22
-
-
0036225350
-
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: Antitumor activity and correlation with vascular endothelial growth factor levels
-
DOI 10.1093/annonc/mdf013
-
Colleoni M, Rocca A, Sandri MT, Zorzino L, Masci G, Nolè F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, Viale G, Goldhirsch A (2002) Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumour activity and correlation with vascular endothelial growth factor levels. Ann Oncol 13:73-80 (Pubitemid 34436728)
-
(2002)
Annals of Oncology
, vol.13
, Issue.1
, pp. 73-80
-
-
Colleoni, M.1
Rocca, A.2
Sandri, M.T.3
Zorzino, L.4
Masci, G.5
Nole, F.6
Peruzzotti, G.7
Robertson, C.8
Orlando, L.9
Cinieri, S.10
De Braud, F.11
Viale, G.12
Goldhirsch, A.13
-
23
-
-
68949180445
-
Metronomic chemotherapy: Changing the paradigm that more is better
-
Scharovsky OG, Mainetti LE, Rozados VR (2009) Metronomic chemotherapy: changing the paradigm that more is better. Curr Oncol 16:7-15
-
(2009)
Curr Oncol
, vol.16
, pp. 7-15
-
-
Scharovsky, O.G.1
Mainetti, L.E.2
Rozados, V.R.3
-
24
-
-
33644789357
-
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients
-
DOI 10.1200/JCO.2005.12.147
-
Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici L, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E, Francini G (2005) Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumour activity in metastatic colon cancer patients. J Clin Oncol 23:8950-8958 (Pubitemid 46211480)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.35
, pp. 8950-8958
-
-
Correale, P.1
Cusi, M.G.2
Tsang, K.Y.3
Del, V.M.T.4
Marsili, S.5
La, P.M.6
Intrivici, C.7
Aquino, A.8
Micheli, L.9
Nencini, C.10
Ferrari, F.11
Giorgi, G.12
Bonmassar, E.13
Francini, G.14
-
25
-
-
45749134564
-
The anticancer immune response: Indispensable for therapeutic success?
-
DOI 10.1172/JCI35180
-
Zitvogel L, Apetoh L, Ghiringhelli F, André F, Tesniere A, Kroemer G (2008) The anticancer immune response: indispensable for therapeutic success? J Clin Invest 118:1991-2001 (Pubitemid 351872317)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.6
, pp. 1991-2001
-
-
Zitvogel, L.1
Apetoh, L.2
Ghiringhelli, F.3
Andre, F.4
Tesniere, A.5
Kroemer, G.6
-
26
-
-
33748052024
-
The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients
-
DOI 10.1158/0008-5472.CAN-05-4201
-
Sommerfeldt N, Schütz F, Sohn C, Förster J, Schirrmacher V, Beckhove P (2006) The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients. Cancer Res 66:8258-8265 (Pubitemid 44299195)
-
(2006)
Cancer Research
, vol.66
, Issue.16
, pp. 8258-8265
-
-
Sommerfeldt, N.1
Schutz, F.2
Sohn, C.3
Forster, J.4
Schirrmacher, V.5
Beckhove, P.6
-
27
-
-
2242419092
-
Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense
-
DOI 10.1126/science.1076064
-
Messaoudi I, Guevara Patin JA, Dyall R, LeMaoult J, Nikolich-Zugich J (2002) Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 298:1797-1800 (Pubitemid 35404125)
-
(2002)
Science
, vol.298
, Issue.5599
, pp. 1797-1800
-
-
Messaoudi, I.1
Guevara, P.J.A.2
Dyall, R.3
LeMaoult, J.4
Nikolich-Zugich, J.5
-
28
-
-
54449099774
-
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer
-
Dellapasqua S, Bertolini F, Baqnardi V, Campagnoli E, Scarano E, Torrisi R, Shaked Y, Mancuso P, Goldhirsch A, Rocca A, Pietri E, Colleoni M (2008) Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer. J Clin Oncol 26:4899-4905
-
(2008)
J Clin Oncol
, vol.26
, pp. 4899-4905
-
-
Dellapasqua, S.1
Bertolini, F.2
Baqnardi, V.3
Campagnoli, E.4
Scarano, E.5
Torrisi, R.6
Shaked, Y.7
Mancuso, P.8
Goldhirsch, A.9
Rocca, A.10
Pietri, E.11
Colleoni, M.12
-
29
-
-
0036897097
-
Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs
-
Bocci G, Nicolaou KC, Kerbel RS (2002) Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 62:6938-6943 (Pubitemid 35424084)
-
(2002)
Cancer Research
, vol.62
, Issue.23
, pp. 6938-6943
-
-
Bocci, G.1
Nicolaou, K.C.2
Kerbel, R.S.3
-
30
-
-
27644436870
-
Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity
-
DOI 10.1182/blood-2005-04-1422
-
Shaked Y, Emmenegger U, Man S, Cervi D, Bertolini F, Ben-David Y, Kerbel RS (2005) Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity. Blood 106:3058-3061 (Pubitemid 41565900)
-
(2005)
Blood
, vol.106
, Issue.9
, pp. 3058-3061
-
-
Shaked, Y.1
Emmenegger, U.2
Man, S.3
Cervi, D.4
Bertolini, F.5
Ben-David, Y.6
Kerbel, R.S.7
-
31
-
-
77953730756
-
+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels
-
+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels. Cancer Res 70:4850-4858
-
(2010)
Cancer Res
, vol.70
, pp. 4850-4858
-
-
Zhao, J.1
Cao, Y.2
Lei, Z.3
Yang, Z.4
Zhang, B.5
Huang, B.6
-
32
-
-
77953945438
-
Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
-
Nakahara T, Uchi H, Lesokhin AM, Avogadri F, Rizzuto GA, Hirschhorn-Cymerman D, Panageas KS, Merghoub T, Wolchok JD, Houghton AN (2010) Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs. Blood 115:4384-4392
-
(2010)
Blood
, vol.115
, pp. 4384-4392
-
-
Nakahara, T.1
Uchi, H.2
Lesokhin, A.M.3
Avogadri, F.4
Rizzuto, G.A.5
Hirschhorn-Cymerman, D.6
Panageas, K.S.7
Merghoub, T.8
Wolchok, J.D.9
Houghton, A.N.10
-
33
-
-
70350108862
-
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
-
Radojcic V, Bezak KB, Skarica M, Pletneva MA, Yoshimura K, Schulick RD, Luznik L (2010) Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination. Cancer Immunol Immunother 59:137-148
-
(2010)
Cancer Immunol Immunother
, vol.59
, pp. 137-148
-
-
Radojcic, V.1
Bezak, K.B.2
Skarica, M.3
Pletneva, M.A.4
Yoshimura, K.5
Schulick, R.D.6
Luznik, L.7
-
34
-
-
0036669298
-
CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice: Implications for the nonredundant function of IL-2
-
DOI 10.1016/S1074-7613(02)00367-9
-
Malek TR, Yu A, Vincek V, Scibelli P, Kong L (2002) CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17:167-178 (Pubitemid 35245959)
-
(2002)
Immunity
, vol.17
, Issue.2
, pp. 167-178
-
-
Malek, T.R.1
Yu, A.2
Vincek, V.3
Scibelli, P.4
Kong, L.5
-
36
-
-
0034716925
-
Regulatory T cells: Key controllers of immunologic self-tolerance
-
Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458
-
(2000)
Cell
, vol.101
, pp. 455-458
-
-
Sakaguchi, S.1
-
37
-
-
0038153907
-
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
-
DOI 10.1073/pnas.1533209100
-
Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA (2003) Cancer regression and autoimmunity induced by cytotoxic T lymphocyte associated antigen-4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 100:8372-8377 (Pubitemid 36842552)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.14
, pp. 8372-8377
-
-
Phan, G.Q.1
Yang, J.C.2
Sherry, R.M.3
Hwu, P.4
Topalian, S.L.5
Schwartzentruber, D.J.6
Restifo, N.P.7
Haworth, L.R.8
Seipp, C.A.9
Freezer, L.J.10
Morton, K.E.11
Mavroukakis, S.A.12
Duray, P.H.13
Steinberg, S.M.14
Allison, J.P.15
Davis, T.A.16
Rosenberg, S.A.17
|